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Abstract
Background: Milk is the sole source of nutrients for neonatal mammals and is generally considered to have co-evolved with
the developmental needs of the suckling newborn. One evolutionary conserved constituent of milk and present on many
glycoconjugates is sialic acid. The brain and colon are major sites of sialic acid display and together with the liver also of
synthesis.
Methodology/Principal Findings: In this study we examined in rats the relationship between the sialic acid content of milk
and the uptake, utilization and synthesis of sialic acid in suckling pups. In rat milk sialic acid was found primarily as
39sialyllactose and at highest levels between 3 and 10 days postpartum and that decreased towards weaning. In the liver of
suckling pups sialic acid synthesis paralleled the increase in milk sialic acid reaching and keeping maximum activity from
postnatal day 5 onwards. In the colon, gene expression profiles suggested that a switch from sialic acid uptake and
catabolism towards sialic acid synthesis and utilization occurred that mirrored the change of sialic acid in milk from high to
low expression. In brain sialic acid related gene expression profiles did not change to any great extent during the suckling
period.
Conclusions/Significance: Our results support the views that (i) when milk sialic acid levels are high, in the colon this sialic
acid is catabolized to GlcNAc that in turn may be used as such or used as substrate for sialic acid synthesis and (ii) when milk
sialic acid levels are low the endogenous sialic acid synthetic machinery in colon is activated.
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Introduction
Among the nine monosaccharides that are used as building
blocks for mammalian glycans, sialic acid (Sia) is special. First, it is
a key determinant of numerous glycan-receptor interactions
involved in cell interaction and communication processes pertinent
to health and disease [1–3]. Second, it is present in the free
oligosaccharide fraction of most if not all mammalian milks [4] at
levels that vary with species and time of lactation. Sia is thus
amongst the first compounds ingested by the suckling newborn
and this raises the question of whether or not milk Sia serves as a
nutrient.
All mammals have the synthetic machinery for de novo synthesis
of Sia, which begins with either fructose-6P and glutamine or N-
acetylglucosamine and requires a series of enzymatic reactions (the
biosynthesis of Sia is reviewed in [5]). The rate limiting step is
catalysed by GNE (UDP-N-acetylglucosamine N-acetylmannosa-
mine epimerase/kinase). While the synthetic machinery is present
in many organs it is not clear if it is ubiquitous. In addition the
absolute expression and/or activity of each gene product can vary
per tissue or cell type. In adult mouse, GNE mRNA expression is
highest in the liver followed by the lung and kidney [6] while Sia
concentration measured in the spleen, brain and lung is
considerably greater than in the liver or kidney [7]. In adult rats,
considerable GNE activity has been measured in the liver, salivary
gland and small intestinal mucosa while in other tissues including
spleen, brain and lung the GNE activity is very low [8].
Interestingly, GNE activity in the liver of rats and guinea pigs
has been reported to be low early in life during the post-natal
suckling period when sialylation is considered essential for normal
development and to rise significantly thereafter [9].
The brain is the major site of Sia display and has been suggested
to depend on an exogenous supply during growth and develop-
ment [10,11]. Muchmore also reported that in the colon and
thymus and to a lesser extent in the small intestine of the neonatal
rat there is a significant albeit transient increase in Sia display in
the days immediately following birth [12]. Thus as for the brain
the early postnatal colon might need an exogenous supply of Sia to
cope with its high needs. Such results have lead to speculation that
during the neonatal suckling period de novo Sia production may not
be sufficient to meet the needs of all tissues in the rapidly
developing newborn and that Sia could serve as a conditionally
essential nutrient for the suckling neonate [13].
The uptake of Sia from an exogenous, say dietary, source is
thought to initiate at the plasma membrane through endocytosis.
Once intracellular the material within the endocytic vesicle is
delivered to the lysosome where bound Sia is removed by a
resident neuraminidase and then transported out into the cytosol
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be activated through conjugation to CMP after which it is suitable
to be used by Golgi-resident sialyltransferases to decorate
glycoproteins and glycolipids. Alternatively, Sia was also proposed
to be catabolized to N-acetylmannosamine and pyruvate [15].
Human and rodent milk is a rich source of Sia in the form of
sialyloligosaccharides and thus it may be a valuable Sia supply for
the newborn [4,16,17]. Consistent with this idea neuraminidase
activity in rats and mice is highest during the suckling period and
in particular in the middle and distal thirds of small intestine [18].
Dietary Sia is able to get into brain and other tissues [19,20]
however the mechanism involved and whether Sia is taken up as
such or whether catabolic products reach the brain are largely
unexplored. The small intestine is thought to be a major site of Sia
uptake and as previously mentioned Sia has been proposed to be
catabolised to ManNAc and pyruvate [15] with putative
subsequent resynthesis of Sia.
Not all milk sialyloligosaccharides however, or indeed other
milk oligosaccharides, are digested in the small intestine. The
majority of human milk oligosaccharides seem to reach the colon
where they are available for catabolism by both the microflora and
host, or pass unaltered into the feces [21–23]. Yet their precise
roles and the amount of fermented or colonic digested oligosac-
charide structures are largely unknown.
Given the importance of the suckling period in the development
of the newborn we sought to gain further insight into the
metabolism of Sia through gene expression profiling. Our results
support the view that the high concentration of Sia found in milk
early during lactation favours its catabolism in the colon of the
suckling pup whereas the low concentration seen at weaning
stimulates the expression of genes for its synthesis and subsequent
use.
Materials and Methods
Bioinformatics
The organism and tissue specific pattern of expression of the
genes GNE and Slc17a5 during development was performed with
Genevestigator (http://www.genevestigator.ethz.ch), a microarray
database and analysis system allowing context-driven queries
[24,25]. Additional data was obtained from the NCBI Gene
Expression Omnibus (GEO) [26] and is available through GEO
dataset accession number GDS1273 (http://www.ncbi.nlm.nih.
gov/sites/GDSbrowser?acc=GDS1273).
Animals and Experimental Design
Animal experiments were conducted under authorisation nu
2043 granted by the Service Ve ´te ´rinaire, Etat de Vaud. Seven
timed pregnant Sprague Dawley rats were obtained from Charles
River Laboratories (France). The animals were individually
housed, had ad libitum access to food and water and were
maintained in a 12 hr light/dark cycle.
One day before giving birth one dam was anaesthetized with
isoflurane and pups were removed by Caesarean section and
dissected as described below. At birth litter sizes were adjusted to
10 pups per dam by culling or supplementation with pups from
litters of the same birth date. Pups were weighed and then
sacrificed by decapitation and tissues isolated. Intestinal tissue
samples were rinsed with ice cold PBS to remove luminal material.
The brain was separated into two hemispheres through a mid-
coronal cut. All tissue samples were snap frozen in liquid N2 and
kept frozen at 280uC before analysis.
Non-stimulated rat milk was obtained from Charles River
Laboratories.
Microarray Analysis
Brain and colon tissue samples (approximately 10 mg wet
weight) were disrupted and homogenized in lysis buffer using a
FastPrep instrument and lysing tubes containing ceramic beads
(MP Biomedicals). Total RNA was then extracted and purified
with the RNAdvance tissue kit (Agencourt) through an
automated procedure on a Hamilton robotic station. After
extraction, RNA was quantified with the RiboGreen RNA
Quantification Kit (Molecular Probes) and monitored for quality
on a Agilent 2100 Bioanalyser (RNA integrity numbers §8f o r
high quality).
All cRNA targets were synthesized, labelled and purified
according to the Illumina TotalPrep RNA amplification protocol
(Applied Biosystems/Ambion) using the Hamilton robotic station.
Briefly, 200 ng total RNA was used to produce double-stranded
cDNA followed by in vitro transcription and cRNA labelling with
biotin. 750 ng biotin-labelled cRNA was added to the hybridiza-
tion mix, which contained control oligonucleotides (such as
negative and hybridization controls), hybridization buffer, and
water. Then 15 ml of each hybridization mix was applied to each
microarray (RatRef-12 Expression BeadChips (Illumina)). After
overnight hybridization (16 hours, 58uC) the microarrays were
washed to remove non-hybridized material and stained with
Streptavidin-Cy3. Arrays were scanned with a BeadArray Reader
(Illumina). Signal intensities were extracted and summarized in
the BeadStudio software (Illumina). Data were expressed as
absolute intensities. Quality control and filtering of microarray
data was carried out with GeneSpring GX software (Agilent
Technologies). Quality control of the data was performed on all
samples with a Pearson correlation matrix and a Principal
Component Analysis. One outlier (sample Colon_Embryo_
Day21_rep1) was identified (data not shown) and was eliminated
from the analysis. After quantile normalization, data were log2
transformed and analysed by ANOVA. Genes with at least one
time point significantly different at a p,0.01 were selected. Genes
of interest were extracted and for ease of visualization were back
transformed to normalized expression levels. GraphPad Prism
was used to graph figures with mean values and standard
deviation.
Thedata have been depositedinthe GEO[26] andareaccessible
through GEO Series accession number GSE18133 (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18133.)
Carbohydrate Analysis
Sialyllactoses (39 and 69sialyllactoses) and lactose were quanti-
fied based on a previously described method [27]. Briefly,
deproteinated and defatted milk, plasma and urine were subjected
to high performance anion exchange chromatography (HPAEC)
equipped with a CarboPac PA200 analytical column and amino-
trap guard column and a pulsed amperometric detector (Dionex).
Quantification was done using authentic sialyllactoses (Dextra) and
lactose (Fluka).
Sia was quantified following derivatization with DMB (1,2-
diamino-4,5-methylenedioxybenzene dihydrochloride) [28] and
HPLC using a C18 reverse phase column (Zorbax SB-Aq Rapid
Resolution column, Agilent Technologies) and fluorescence
detector. Authentic N-acetylneuraminic acid (NeuAc; Dextra)
and N-glycolylneuraminic acid (NeuGc; Dextra) were used as
external standards.
GNE Assay
GNE epimerase activity was assayed based on a previously
described method [29]. Briefly, 30–50 mg pieces of frozen liver
were homogenised in lysis buffer (10 mM Tris pH 8, 0.2% (v/v)
Sialic Acid in the Neonate
PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8241NP-40, 1x complete protease inhibitors (Roche)) using a
TissueLyser (Qiagen) and cleared by centrifugation. Total
protein was measured using the Bio-Rad protein assay according
the manufacturer’s protocol. Supernatants were assayed for GNE
activity in lysis buffer containing 50 mM sodium phosphate
(pH 7.5), 10 mM MgCl2 and 1 mM UDP-GlcNAc (Sigma) at
37uC. Reactions were stopped by boiling and samples were
subjected to HPAEC equipped with a CarboPac PA1 and PA1
guard column and a pulsed amperometric detector (Dionex).
Quantification was done using authentic N-Acetyl-D-mannosa-
mine (Sigma) as external standard. HPAEC running conditions
were as follows: each run was preceded with a washing (4 min
isocratic 500 mM NaOAc followed by 8 min isocratic 300 mM
NaOH) and equilibration (14 min isocratic 15 mM NaOH) step.
Sample running conditions were 25 min isocratic 15 mM
NaOH.
Figure 1. Gene expression levels of GNE and Slc17a5. A) Relative GNE (sialic acid synthesis) and Slc17a5 (sialic acid uptake) expression levels in
the central nervous system (CNS), liver and small and large intestine throughout development and aging in the mouse, rat and human. (E, embryonic;
d, day; w, week; y, year; dashed line, not determined). B) GNE and Slc17a5 expression in the intestine of 17 and 21 day old rat pups. The data was
extracted from the Gene Expression Omnibus repository at http://www.ncbi.nlm.nih.gov/sites/GDSbrowser?acc=GDS1273. Mean and SD are shown;
N=3, except PND17 colon, N=2.
doi:10.1371/journal.pone.0008241.g001
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Synthesis and Uptake of Sia Seen through Public Gene
Expression Data
Using publicly available microarray gene expression data from
mouse, rat and human we monitored the RNA expression profiles
of GNE and Slc17a5, genes involved in Sia synthesis and uptake
respectively, over time in the brain, liver and gut (Fig. 1A). In the
mouse, GNE expression was relatively high in both the colon and
liver, while in human GNE expression was lower in the colon than
in the liver. To complement the data available for the rat we
included gene expression data for the intestine from GEO dataset
GDS1273 [29] (Fig. 1B). GNE transcript levels were higher in
colon than small intestine and high transcript levels were seen both
at postnatal day 17 and 21. The most complete developmental
profile of GNE was established for mouse liver wherein an increase
was seen within the first days after birth with maximal expression
occurring before weaning (usually at 21 days post-partum)
(Fig. 1A). It is worth noting that while membrane fractions from
brain tissue contain proportionally more Sia than membrane
fractions from the liver [7] the expression of GNE there was
relatively low compared to that in liver. The brain may therefore
depend upon Sia synthesized elsewhere.
Gene expression data of the Sia transporter Slc17a5 was most
complete in mice where highest expression was found in the small
intestine during the suckling period. A similar picture was seen in
rat where highest Slc17a5 transcript levels were expressed in the
ileum at PND17 as compared to after weaning at PND21 (Fig. 1B).
Although many time points are missing this suggests that
maximum Sia uptake in the small intestine occurs at times when
Sia is supplied via the milk to the pup. The data further suggest
that highest uptake occurs in the lower small intestine. In the
central nervous system no major peak of expression of Slc17a5 was
observed although the limited data available do not allow us to
suggest whether or not there is increased Sia uptake into brain
during the suckling period.
Sialyllactose Levels in Rat Milk Change over Lactation
We collected non-stimulated milk and analysed its content in
lactose, sialyllactose and total Sia (Fig. 2). Lactose in milk increased
throughout the first week of lactation, dropped slightly at 10 days
postpartum and then increased further towards weaning. Besides
the 39- and 69sialyllactoses no other oligosaccharides were
detected. 39Sialyllactose was the major oligosaccharide detected
and was found at an ever increasing level during the first week of
lactation but thereafter dropped steadily. 69Sialyllactose was found
at about ten times lower levels and also showed an increase over
the first week of lactation. It then remained at a constant although
low level until weaning.
The total amount of Sia in milk showed a similar profile
throughout lactation to that of 39sialyllactose and was consistent
with previously published results [16,18]. The total level increased
during the first week of lactation with a peak at 5 to 7 days
postpartum and then a steady decrease towards weaning. Almost
all Sia present in rat milk was found to be present in the form of
39sialyllactose and was exclusively N-acetylneuraminic acid.
With this we asked whether and how Sia related gene
expression profiles change over the suckling period in colon and
brain.
Gene Expression Profiles in Colon Indicate Sia Catabolism
Followed by Anabolism over Lactation
We have depicted schematically (Fig. 3) the endogenous pathway
for de novo Sia synthesis and possible routes for the metabolism of Sia
in the newborn rat from milk-born 39sialyllactose based on the
KEGG amino sugar pathway [30] and literature data.
During the first half of lactation the high 39sialyllactose in milk was
accompanied by high colonic expression of neuraminidase 1 (Neu1)
and of the Sia transporter Slc17a5 (Fig. 4B). Together, this suggests
that there is colonic cleavage and uptake of Sia during the suckling
period when 39sialyllactose delivery via milk is high (Figs. 3 and 4B).
In order to be added to glycan chains free Sia must be activated
to CMP-Sia by the enzyme CMAS (CMP-N-acetylneuraminic
Figure 2. Rat milk lactose, sialyllactose and sialic acid content
throughout lactation. Lactose (upper panel), the sialyllactoses
(middle panel; 3SL left scale bar; 6SL right scale bar) and total sialic
acid (lower panel) contents were measured in non-stimulated rat milk
over time of lactation. Amounts are expressed in g per 100 g dried milk.
Mean and SD are shown (N=5).
doi:10.1371/journal.pone.0008241.g002
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Slc35a1 [31] (Fig. 3). The peak of expression of both CMAS
(Fig. 4C) and Slc35a1 (Fig. 4E) occurred at the end of lactation
rather than the beginning. This suggests that the bulk of free Sia
delivered via milk may follow another metabolic route.
We therefore next looked at the expression of genes whose
products could potentially catabolise dietary derived Sia. Npl (N-
acetylneuraminate lyase) transcript levels peaked transiently at
postnatal day 3 and mirrored the expression profile of milk
39sialyllactose (Fig. 4D). Similarly renin binding protein (Renbp,N -
acetyl-D-glucosamine 2-epimerase) also increased to postnatal day
3 and was followed by a decrease to day 10 (Fig. 4D). Npl catalyses
the breakdown of N-acetylneuraminate to N-acetyl-D-mannosa-
mine (ManNAc) and pyruvate. Renbp epimerizes ManNAc to N-
acetyl-D-glucosamine (GlcNAc) and vice versa.
GlcNAc, the product of the sequential Npl and Renbp
reactions, can then itself follow one or more metabolic fates. It
can either be degraded further to glucosamine, be transported out
of the cell or be used by glycosyltransferases for glycosylation
reactions. Currently we do not have data to support or refute
either of the first two possibilities. The biochemical pathway
leading from GlcNAc to UDP-GlcNAc for use in glycosylation
involves the enzymes NAGK (GlcNAc-kinase), Pgm3 (phospho-
glucomutase 3) and Uap1/Uap1l1 (UDP-N-acetylglucosamine
pyrophosphorylase 1/UDP-N-acetylglucosamine pyrophosphory-
lase 1-like 1). Subsequently, UDP-GlcNAc may be used by OGT
(O-GlcNAc transferase) or transported into the Golgi apparatus by
Slc35a3 for use by different glycosyltransferases. NAGK transcript
levels did not change much during suckling (Fig. 5A). Uap1-like1
had a transient increase shortly after birth similar to Npl and Renbp,
while Uap1 increased only later at weaning (Fig. 5C). GFAT
(glucosamine-fructose-6phosphate-aminotransferase), the key en-
zyme for de novo GlcNAc synthesis, showed no change during early
suckling but had a dramatic increase at the onset of weaning
(Fig. 5B). Finally, the transporter of UDP-GlcNAc into the Golgi,
Slc35a3, only showed a major change in expression at weaning
(Fig. 4F) while that of OGT remained unchanged throughout
(Fig. 3; expression profile not shown).
UDP-GlcNAc is also an intermediate in the de novo synthesis of
Sia as a substrate for the rate-limiting enzyme GNE. In colon, de
novo synthesis of UDP-GlcNAc was higher after weaning than
during the suckling period as can be deduced from the gene
expression profiles of GFAT and Uap1 presented in figure 5.
Expression of GNE and of the downstream enzyme NANS (N-
acetylneuraminic acid synthase) mirrored this being higher at
weaning than earlier during the suckling period (Fig. 4A).
Together, the expression profiles found in rat colon suggest that
milk Sia is taken up and catabolized to N-acetylglucosamine
Figure 3. Schematic representation of sialic acid metabolism and a summary of gene expression levels in the colon. The pathways
depicted are based on the KEGG aminosugar reference pathway. Full names of the indicated gene/protein are given in the text. The relative gene
expression level and milk sialic acid content during first and third week of lactation are indicated by symbols and color code. (*Gene not in array or
not expressed; ‘?’ no data that pgm1 can catalyse this step.)
doi:10.1371/journal.pone.0008241.g003
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endogenous Sia anabolic route in the colon is favoured as judged
from the respective gene expression profiles.
Plasma and Urine Sialyllactose Levels Were Highest
during Times of High Sialyllactose Concentration in Milk
As milk oligosaccharides were reported to be excreted through
urine we analysed plasma and urine throughout the suckling
period for the presence of 39sialyllactose, N-acetylneuraminic acid
and its putative catabolic product N-acetylglucosamine.
In plasma, we detected 39sialyllactose, but neither free Sia nor
GlcNAc (Fig. 6A). The plasma 39sialyllactose concentration was
high until PND 7 and then dropped continuously until PND 22. In
urine, both 39sialyllactose and free Sia were detected (Fig. 6B). The
39sialyllactose content increased until PND 7 and then decreased
steadily until PND 22. Free Sia showed a similar increase in the
first days after birth until PND 7 but then remained constant to
PND 15 and then dropped slightly by PND 22 (Fig. 6B).
Liver Sia Synthetic Activity Increases in Parallel with
Increased Sia Content in Milk
The liverisgenerallyconsideredtobeamajorsiteforthesynthesis
Sia. This synthetic activity is reported to be low at birth and to
increase towards weaning [9]. We measured the epimerase activity
of GNE in the liver in suckling rats and found a steady increase in
activity from prenatal day 1 to postnatal day 7. Thereafter, the GNE
epimerase activity dropped slightly at 10 days and then stabilized
towards weaning (Fig. 7). Interestingly, the GNE epimerase activity
Figure4.Colon geneexpressionlevels insuckling rat pups. A–F) Filledsymbolsapply totheleftscalebarandopen symbolstotherightscale bar.
Mean and SD are shown (N=6, except PND-1 N=5). The bar above each x-axis indicates the relative level of sialic acid in milk (low, open and high, filled).
doi:10.1371/journal.pone.0008241.g004
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measured in milk. This suggests that a metabolic signal may exist
between the dietary Sia and liver GNE epimerase activity. This
could be sialyllactose, Sia or one of its catabolic products.
Sia Metabolism Related Gene Expression Profiles in Brain
Do Not Change Much over Time
The brain has been suggested to use an exogenous supply of Sia
for development and growth [10,11]. To determine how the brain
reacts to ingested milk sialyllactose we measured gene expression
levels throughout the suckling period. The endogenous Sia
synthetic route with GNE, NANS and CMAS showed a relatively
constant expression profile from birth to the end of weaning
(Fig. 8A & C). The CMP-Sia transporter Slc35a1 showed a low but
constant reduction in expression throughout (Fig. 8E) which
suggests that less Sia incorporation in glycoconjugates occurs as
the pups are weaned. As for genes potentially involved in an
exogenous supply of Sia to the brain expression of Neu1 was
relatively constant while that of the Sia transporter Slc17A5 was
marginally higher from PND 2 to 7 (Fig. 8B). Npl and Renbp both
had a peak of expression at PND 5 and whereas Npl expression
was stable or declining by weaning that of Renbp was increasing
(Fig. 8D). Finally in the metabolism of GlcNAc NAGK had a peak
of expression in the first two days following birth and then declined
slowly to weaning. Expression of Uap1 on the other hand was
constant throughout the suckling period (Fig. 8F).
The slight changes in gene expression do neither favour the
endogenous biosynthetic pathway nor an exogenous supply as a
primary source of Sia during early brain growth and development.
Figure 5. Colon gene expression levels in suckling rat pups. A–
C) Filled symbols apply to the left scale bar and open symbols to the
right scale bar. Mean and SD are shown (N=6, except PND-1 N=5). The
bar above each x-axis indicates the relative level of sialic acid in milk
(low, open and high, filled).
doi:10.1371/journal.pone.0008241.g005
Figure 6. Sialyllactose and sialic acid levels in plasma and urine
of suckling rat pups. A) Plasma 39sialyllactose (3SL) and B) urine 3SL
and free sialic acid (NeuAc) levels were determined in pups throughout
the suckling period. Mean and SD are shown (N=6). The bar above
each x-axis indicates the relative level of sialic acid in milk (low, open
and high, filled).
doi:10.1371/journal.pone.0008241.g006
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Given the importance of the suckling period in the development
of the newborn rat we sought to gain further insight into the
synthesis and metabolism of Sia. To achieve this we compared
throughout the suckling period the concentration of Sia in milk
with (i) the expression profiles of genes involved in Sia metabolism
in the colon and brain, major sites of synthesis and incorporation
of Sia, and (ii) the Sia synthetic capacity in the liver, also a major
site of synthesis. It is worth emphasizing that the results of gene
expression profiling do not necessarily correlate with the
corresponding gene product levels, their catalytic activities or the
flux of their substrates and products. Gene expression results do
however provide important data that can be used to direct
subsequent research.
Early in lactation Sia levels, principally as 39sialyllactose, were
highest and in the colon this correlated with the expression profile
of catabolic genes. This suggests that Sia can be cleaved from
sialyl-glycoconjugates, absorbed and subsequently catabolised to
yield ManNAc, pyruvate and subsequently GlcNAc. These
findings support the notion that milk Sia is a nutrient for the
suckling neonate. At the end of weaning, when Sia levels in milk
were lowest, colonic gene expression had switched such that those
involved in de novo UDP-GlcNAc and CMP-Sia synthesis together
with their respective Golgi resident transporters showed the
highest relative expression. Thus, in the colon as the dietary source
of Sia diminishes the body may compensate by up regulating Sia
synthetic genes.
Several lines of evidence have lead others to suggest that milk
Sia can be a nutrient for the neonate early during the suckling
period. Over 3 decades ago a correlation was described between
the neuraminidase activity in the middle and distal small intestine
and the milk Sia content that led the authors to suggest that milk
Sia is liberated and used by the suckling newborn [18]. In
accordance, high Sia uptake is suggested from the high transient
expression of Slc17a5 in the distal small intestine and of Neu1 and
Slc17a5 in the colon. Interestingly beyond uptake genes we also
saw Npl and Renbp upregulated during the period when the
concentration of Sia in milk was at its peak. While these two genes
are part of the same biochemical pathway the direction of reaction
is unclear (Fig. 3). Together Npl and Renbp may drive an
alternative Sia synthetic route that is active when GNE expression
is low or a catabolic route during times when Sia delivery is high.
The former is possible but unlikely because GNE knockout mice
are embryo lethal and the GNE deficient cells that were tested
cannot make Sia from GlcNAc indicating that no salvage pathway
exists [32]. It is thus more likely that Npl and Renbp catalyse the
catabolism of Sia to GlcNAc. Indeed, Npl was reported to be
mainly involved in Sia catabolism in vivo [33], and Renbp is
thought to epimerize ManNAc to GlcNAc rather then the reverse
[34]. It would be interesting to determine if the same expression
profiles of Npl and Renbp occur in the small intestine. Finally results
from tracer feeding experiments support the view that nutritionally
supplied Sia (as sialyllactose or free Sia) can be a nutrient and
preferentially early during the suckling period [15,19,20,35,36]. In
3 day old rat pups approximately 30% of administered
radioactivity remained in the body after 6 hr while 70% was
excreted via the lungs (i.e. as CO2), kidney and feces [20]. In 20
day old mice only approximately 1.5% of the administered
radioactivity was retained in the body after 6 hr [19]. Morgan and
Winick also showed that newborn rats incorporate considerably
more tracer early during the suckling period than at the end of
weaning [37]. While the nature of the labelled molecule(s) present
in the tissues was not identified in these studies No ¨hle and Schauer
proposed a model where Sia is cleaved from a glycoconjugate
followed by Npl catalysed cleavage to ManNAc and pyruvate [19].
Our results support this model and suggest that ManNAc can be
further epimerized by Renbp to GlcNAc.
The brain incorporates a large amount of Sia during
development which begins in utero but continues postnatally (data
not shown; [38,39]). Postnatally the sources and their relative
contributions of Sia for use in the brain (e.g. synthesized within the
brain, in another tissue (e.g. liver) or from the diet) are currently
unknown. The Sia transporter Slc17a5 has been reported to be
expressed throughout the adult rodent brain and during
embryonic development highest levels are seen in the central
and peripheral nervous system [40]. Also radioactivity from
radiolabelled Sia (either as free sugar or as sialyllactose)
administered to suckling animals can reach the brain although
the biochemical pathway followed is not known [19,20,36]. Such
results have led to the suggestion that the brain gets at least some
of its Sia from exogenous sources [10,11]. Our gene expression
results in the neonatal brain do not provide additional evidence for
a significant use of exogenous Sia during this time. Studying the
brain as a whole as was done here may have masked important
regional differences where significant use of exogenously supplied
Sia occurs.
The liver may be a source of Sia for other tissues and organs. In
the liver the epimerase activity of GNE, the rate limiting enzyme
of Sia synthesis, increased during the first week of lactation in
parallel to the milk Sia concentration. Whether milk Sia is the
stimulus for this activity increase is unknown however Wang et al.
have previously shown that piglets provided a diet enriched in Sia
increased expression of GNE mRNA in both the liver and
hippocampus [41]. At present we do not know if rat liver GNE
gene expression parallels that of its enzymatic activity during early
development.
Ingested milk oligosaccharides are also excreted unaltered and
in significant amounts in the urine and feces [19,21–23]. In human
infants about 0.5 to 1% of ingested milk oligosaccharides were
reported to be excreted in urine [23,42]. In rats we also found part
of the ingested sialyllactose in urine and estimated that maximally
1% of ingested sialyllactose was excreted into urine (data not
shown).
Figure 7. GNE activity in the livers of suckling rat pups. GNE
epimerase activity was determined in liver extracts throughout the
suckling period. Mean and SD are shown (N=6). The bar above the x-
axis indicates the relative level of sialic acid in milk (low, open and high,
filled).
doi:10.1371/journal.pone.0008241.g007
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What is the biological role of the bulk of ingested sialyllactose that
is not digested and (ii) what is the selective advantage of delivering
Sia to thesuckling pup instead of ManNAcorGlcNAc?A possible
answer to both questions is their decoy function. Indeed there is a
longstanding hypothesis that milk oligosaccharides serve a decoy
function to prevent potentially dangerous microbes from doing
harm to the immunologically fragile neonate by reducing
microbe-host interactions [43]. Along the same lines free milk
oligosaccharides such as sialyllactoses may modulate interactions
directly within the host. This could include interactions between
cells, between receptor and ligands and between receptors and
co-receptors. Such modulation is to date largely unexplored.
Further, systemically circulating sialyllactose may serve as a
source of Sia for extra-intestinal tissues such as the brain as
suggested above.
There is thus good evidence that milk Sia is digested in the
neonatal gut and used as a nutrient and that it may be partially
catabolized to pyruvate, ManNAc and GlcNAc. To our
knowledge it is not known to what extent or where these
catabolic products are reused for Sia synthesis, used as such or
further catabolized. A detailed understanding of the metabolic
fate of dietary Sia is needed to answer these questions and could
provide insight into the possible evolutionary advantages of
expressing high levels of Sia rather than ManNAc or GlcNAc in
milk.
Figure 8. Brain gene expression levels in suckling rat pups. A–F) Filled symbols apply to the left scale bar and open symbols to the right scale
bar. Mean and SD are shown (N=6). The bar above each x-axis indicates the relative level of sialic acid in milk (low, open and high, filled).
doi:10.1371/journal.pone.0008241.g008
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